JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M500620200 on February 10, 2005

J. Biol. Chem., Vol. 280, Issue 19, 18842-18852, May 13, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/19/18842    most recent
M500620200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanos, T.
Right arrow Articles by Coso, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanos, T.
Right arrow Articles by Coso, O. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phosphorylation of c-Fos by Members of the p38 MAPK Family

ROLE IN THE AP-1 RESPONSE TO UV LIGHT*

Tamara Tanos{ddagger}§, Maria Julia Marinissen¶, Federico Coluccio Leskow{ddagger}, Daniel Hochbaum{ddagger}, Horacio Martinetto||, J. Silvio Gutkind¶, and Omar A. Coso{ddagger}**

From the {ddagger}Laboratorio de Fisiología y Biología Molecular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ifibyne-Conicet, 1428 Buenos Aires, Argentina, Oral and Pharyngeal Cancer Branch, NIDR, National Institutes of Health, Bethesda, Maryland 20892, and ||Instituto de Investigaciones en Ingenieria Genetica (Ingebi-Conicet), Universidad de Buenos Aires, 1428 Buenos Aires, Argentina

Received for publication, January 18, 2005


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Exposure to sources of UV radiation, such as sunlight, induces a number of cellular alterations that are highly dependent on its ability to affect gene expression. Among them, the rapid activation of genes coding for two subfamilies of proto-oncoproteins, Fos and Jun, which constitute the AP-1 transcription factor, plays a key role in the subsequent regulation of expression of genes involved in DNA repair, cell proliferation, cell cycle arrest, death by apoptosis, and tissue and extracellular matrix remodeling proteases. Besides being regulated at the transcriptional level, Jun and Fos transcriptional activities are also regulated by phosphorylation as a result of the activation of intracellular signaling cascades. In this regard, the phosphorylation of c-Jun by UV-induced JNK has been readily documented, whereas a role for Fos proteins in UV-mediated responses and the identification of Fos-activating kinases has remained elusive. Here we identify p38 MAPKs as proteins that can associate with c-Fos and phosphorylate its transactivation domain both in vitro and in vivo. This phosphorylation is transduced into changes in its transcriptional ability as p38-activated c-Fos enhances AP1-driven gene expression. Our findings indicate that as a consequence of the activation of stress pathways induced by UV light, endogenous c-Fos becomes a substrate of p38 MAPKs and, for the first time, provide evidence that support a critical role for p38 MAPKs in mediating stress-induced c-Fos phosphorylation and gene transcription activation. Using a specific pharmacological inhibitor for p38{alpha} and -{beta}, we found that most likely these two isoforms mediate UV-induced c-Fos phosphorylation in vivo. Thus, these newly described pathways act concomitantly with the activation of c-Jun by JNK/MAPKs, thereby contributing to the complexity of AP1-driven gene transcription regulation.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Repeated and prolonged exposure to sunlight and hence to UV radiation causes skin damage that may induce alterations in the DNA and ultimately evolve into skin cancer. Extensive investigation of the response of mammalian cells to UV light has shown that exposure to UV light results in the rapid activation of a group of enzymes known as stress-activated protein kinases (SAPKs)1 (1, 2) and the induction of expression of a set of immediate early genes (ergs) (36), which in turn participate in the cellular responses to this type of environmental stress.

SAPKs is the common denomination for a subgroup of highly homologous proteins, JNKs and p38s, that belong to a superfamily of serine-threonine kinases known as mitogen-activated protein kinases (MAPKs) (710). These kinases play an essential role in the transduction of environmental stimuli to the nucleus, as they are capable of regulating the expression of genes involved in a variety of cellular processes, including cell proliferation, differentiation, programmed cell death, and neoplastic transformation (1113). MAPKs have been classified into at least six subfamilies, among which the Erk/MAPKs (Erk1 and -2), JNKs (JNK1, -2, and -3), and p38 kinases ({alpha}, {beta}, {gamma}, and {delta}) are the most extensively studied. Erk5 (also known as Big MAPK or BMPK) (14) and the recently identified ERK7 (15) and ERK8 (16) complete the picture. Whereas Erk1/2 and Erk5 are considered to respond to growth signals (17), JNKs and p38s are activated by cellular stresses like exposure to heat shock, protein synthesis inhibitors such as anisomycin, free radicals, ionizing radiation, and UV light (1821). A variety of mitogens acting on cell surface cellular receptors promote the sequential activation of small GTP-binding proteins of the Ras and Rho family and a cascade of protein kinases that ultimately phosphorylate and activate each MAPK. Indeed, each MAPK is specifically regulated by MAPK kinases (MAPKKs). Despite the knowledge accumulated on agonist-induced MAPK activation, the way stresses are sensed and where and how the signals are converted into SAPKs activation with the consequent triggering of nuclear responses are still open questions.

Among the immediate early genes that are rapidly turned on by UV light are the members of the AP-1 transcription factor family (22), which play a key role in normal and abnormal epithelial cell growth and differentiation (23). This transcription factor is formed by dimers of proteins encoded by the Fos (c-Fos, FosB, Fra-1, and Fra-2) (2428) and the Jun subfamilies (c-Jun, JunD, and JunB) (2933). Homodimerization of Jun proteins or heterodimerization between proteins of the two subfamilies confers to the resulting AP-1 complexes the ability to recognize specific DNA sequences known as tetradecanoylphorbol acetate-responsive elements or AP-1-binding sites (34, 35), which are found in the regulatory regions of a variety of genes (36, 37), including cell cycle-related and AP-1 genes themselves (3840). AP-1 proteins are often the final target of signal-transducing kinase cascades, and upon phosphorylation become transcriptionally active triggering the activity of AP-1-driven promoters and the expression of their corresponding regulated genes (41). The best studied example is the phosphorylation of c-Jun by UV-activated JNK, which in turn acts on AP-1 sequences present on its own promoter. Recently, it has been shown that a parallel pathway involving platelet-derived growth factor-activated Erk2 also leads to the phosphorylation of c-Fos and consequent AP-1 activation (42, 43). In addition, the involvement of the three major MAPK pathways (ERK, JNK, and p38) in the induction of the c-fos promoter has been reported (4446). However, the activation of c-Fos proteins by MAPKs in response to stress-activated signaling pathways has not been investigated extensively.

In this study, we show that c-Fos is rapidly phosphorylated in response to UV light exposure and that this phosphorylation is mostly dependent on UV-induced p38 kinases rather than resulting from Erk1/2 or JNK activation. Moreover, we observed that the phosphorylation of c-Fos in its transactivation domain leads to c-Fos transcriptional activation and to c-Fos-mediated AP-1 activity. In addition, by using an array of point mutations, we examined the contribution of each putative p38 target residue within the c-Fos transactivation domain to its transcriptional response. To the best of our knowledge, this is the first report that involves c-Fos as a target of UV-triggered, p38-mediated signaling pathways that influences AP-1 activity and the subsequent regulation of genes involved in cellular responses to injury caused by DNA-damaging agents.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Culture of Cell Lines—HEK 293T cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum and penicillin/streptomycin/amphotericin B (Invitrogen). NIH 3T3 mouse fibroblasts were grown in Dulbecco's modified Eagle's medium containing 10% calf serum and the above antimicrobial mixture.

Transient Transfections—NIH 3T3 and HEK 293 cells were plated in complete media and allowed to grow overnight to 70–80% confluence in 6-well plates or 6-cm plates. The cells were transfected using Lipofectamine Plus Reagent (Invitrogen), according to the protocol directed by the manufacturer, using up to 2 µg of DNA per transfection.

DNA Constructs—Plasmids carrying the cDNA for the AU5-tagged forms of c-Fos FL and TAD (pCEFL AU5 c-Fos FL and TAD, respectively), pCEFL AU5 c-Fos mut FL, as well as pGal4 c-Fos TAD wt, and its mutants TAD mut, Thr-232, Thr-325, Thr-331, and Ser-374 have been described previously (42). The pCEFL GFP c-Fos plasmids (FL and TAD wt and mutants) were made by shifting the c-Fos fragments from the pCEFL AU5 forms into the pCEFL GFP-tagged vector. pGEX 4T3-c-Fos TAD mutants were constructed by transferring c-Fos cDNA inserts from the different pGal4 TAD constructs as BamHI-NotI fragments to the pGEX 4T3 vector. pAP1-Luc and pGal4-Luc have been described (47). Expression vectors for pCEFL HA-tagged JNK, ERK2, ERK5, p38{alpha}, p38{beta}, p38{gamma}, and p38{delta}, pCEFL-MEKK, pCEV29-MEKEE, pCEFL-GST-MKK6, pcDNA3-MEK3EE and -AA, and pGEX4T3-ATF2 have been described (40, 48). AF (dominant negative) mutant forms of p38{alpha}, -{beta}, -{gamma}, and -{delta} have been provided by J. Han (see Ref. 49).

Bacterial Expression of GST Fusion Proteins—The BL 21 Lys strain of Escherichia coli was transformed with the vector pGEX-4T3 encoding the fusion proteins GST-ATF2 or GST-c-Fos TAD wt, and its mutants TAD mut, Thr-232, Thr-325, Thr-331, and Ser-374. Bacteria were grown in 500 ml of LB medium until the optical density was 0.5, at which time isopropyl-{beta}-thiogalactopyranoside (1 mM final) was added for 3 h. The cells were collected by centrifugation at 3000 x g for 30 min and resuspended in 10 ml of PBS, 1% Triton X-100, 1 mM EDTA, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 1 mM PMSF. The cell suspension was sonicated, and cellular debris was removed by centrifugation at 10,000 x g for 15 min. The supernatant was mixed with 300 µl of glutathione-agarose beads (Amersham Biosciences) and centrifuged at 3000 x g for 5 min. The pellet was washed three times with PBS, 1% Triton X-100, 1 mM EDTA, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 1 mM PMSF and then twice with PBS, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 1 mM PMSF. Finally, purified fusion proteins were eluted in 50 mM Tris, 10 mM glutathione, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 1 mM PMSF.

Kinase Assays—HEK 293 cells were transfected with expression vectors for HA-tagged kinases, alone or in combination with the respective upstream-activating molecules. 24 hours after transfection, cells were starved with serum-free media for 2 h, washed with cold phosphate-buffered saline, and lysed at 4 °C in a buffer containing 25 mM HEPES, pH 7.5, 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 1% Triton X-100, 0.1% SDS, 20 mM {beta}-glycerophosphate, 1 mM sodium vanadate, and 1 mM phenylmethylsulfonyl fluoride (PMSF). HA-tagged kinases were immunoprecipitated from the cleared lysates by incubation with the specific antibody against HA (MMS-101R, Covance) for 1.5 h at 4 °C. Immunocomplexes were recovered with the aid of Gamma-Bind-Sepharose beads (Santa Cruz Biotechnology) and washed three times with PBS containing 1% Nonidet P-40 and 2 mM sodium vanadate, once with 100 mM Tris, pH 7.5, 0.5 M LiCl, and once in kinase reaction buffer (12.5 mM MOPS, pH 7.5, 12.5 mM {beta}-glycerophosphate, 7.5 mM MgCl2, 0.5 mM EGTA, 0.5 mM sodium fluoride, and 0.5 mM sodium vanadate). The kinase activity present in the immunoprecipitates was determined by resuspension in 30 µl of kinase reaction buffer containing 10 µCi of [{gamma}-32P]ATP per reaction and 20 µM of unlabeled ATP, using 1 µg of substrate. After 30 min at 30 °C, the reactions were stopped by the addition of SDS sample buffer (400 mM Tris/HCl, pH 6.8, 10% SDS, 50% glycerol, 500 mM DTT, and 2 µ/ml bromphenol blue) and boiled for 5 min. Denatured samples were resolved by SDS-PAGE on 12% polyacrylamide gels, and autoradiographs were taken from the corresponding dried gels using X-Omat Kodak or AGFA CP-BU films. Parallel immunoprecipitates were processed for Western blot analysis using the same antiserum as described (3840).

Western Blot Analysis—24 hours after transfection cells were washed with PBS twice and resuspended in Lysis buffer (25 mM HEPES, pH 7.5, 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 1% Triton X-100, 0.1% SDS, 20 mM {beta}-glycerophosphate, 1 mM sodium vanadate, and 1 mM PMSF, and 0.4 M NaCl). Cleared lysates were combined with SDS sample buffer, boiled for 5 min, and resolved by SDS-PAGE. Fractionated proteins were blotted to polyvinylidene fluoride membranes (Immobilon-P, Millipore). Nonspecific binding sites were blocked with 5% nonfat-dried milk in PBS containing 0.05% Tween 20 (PBS-T) followed by incubation for 1 h at room temperature with the appropriate dilution of each of these primary antibodies as follows: anti-AU5 epitope from Covance (MMS-135R), anti-c-Fos from Santa Cruz Biotechnology (sc-52X), and anti-GFP from Santa Cruz Biotechnology (sc-9996). Membranes were washed with PBS-T prior to incubation with horseradish peroxidase-conjugated anti-mouse, anti-rabbit, or anti-goat secondary antibodies (Santa Cruz Biotechnology). Immunoreactive protein bands were visualized by enhanced chemiluminescence detection (ECL+Plus System, Amersham Biosciences). Antibodies targeted to the phosphorylated forms of JNK and p38 kinases were obtained from Cell Signaling Technology.

Luciferase Reporter Assays—Cells were seeded on 6-well dishes and transfected with different expression plasmids together with 0.1 µg of luciferase reporter vector and 0.01 µg of pRL-null (a plasmid expressing the enzyme Renilla luciferase from Renilla reniformis). The total amount of transfected DNA was adjusted with pcDNAIII {beta}-galactosidase. Cells were lysed in passive lysis buffer (Promega) 24 h post-transfection. Cell lysates (50 µl/well) were transferred to a 96-well luminometer plate, and firefly and Renilla luciferase activities were assayed using the Dual-luciferase Reporter System (Promega). Light emission was quantitated using the Monolight 2010 luminometer as specified by the manufacturer (Analytical Luminescence Laboratory).

Indirect Immunofluorescence—HEK 293T cells were seeded on glass coverslips and transfected by Lipofectamine Plus Reagents (Invitrogen) as described above. 16–20-h serum-starved cells were washed twice with 1x PBS, fixed, and then permeabilized with 4% formaldehyde and 0.5% Triton X-100 in 1x PBS for 10 min. After washing with PBS, cells were blocked with 1% bovine serum albumin and incubated with anti-HA (Covance) as primary antibodies for 1 h. Following incubation, cells were washed three times with 1x PBS and then incubated with the corresponding secondary antibodies (1:200) conjugated with tetramethylrhodamine B isothiocyanate (Jackson ImmunoResearch). Coverslips were washed three times, mounted in Vectashield mounting medium with 4,6-diamidino-2-phenylindole (Vector Laboratories), and viewed using a Zeiss Axiophot photomicroscope equipped with epifluorescence. To analyze the subcellular localization of GFP-c-Fos in the presence of dominant negative mediators of p38 signaling, we followed the same protocol, and the images were captured on an Olympus Fluoview FV300 laser-scanning confocal microscope.

UV Stimulation—HEK 293 cells were transfected and starved overnight. 24 hours after transfection, the medium was removed, and the cells were irradiated in a UV Stratalinker (Stratagene) with 120 J/m2. Culture medium was then restored, and the cells were returned to the incubator for the indicated times before further analysis.

Electrophoretic Mobility Shift Assays—Nuclear extracts were obtained from HEK 293 cells plated in 10-cm plates and grown to 70% confluence, starved overnight, and then treated with UV light and pretreated with the SB 203580 compound as indicated. Cells were washed in cold PBS and lysed in 400 µl of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF). After 15 min on ice, 25 µl of 10% of Nonidet P-40 was added and vigorously vortexed for 10 s. Homogenates were centrifuged for 30 s in a microcentrifuge. The nuclear pellets were resuspended in 50 µl of ice-cold hypotonic buffer C (20 mM HEPES, pH 7.9, 0.42 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF) and rocked at 4 °C for 15 min on a shaking platform. Homogenates were centrifuged for 5 min, and the supernatants (nuclear extracts) were aliquoted and stored at –70 °C. After determining protein concentrations using protein assay (Bio-Rad Laboratories), 2 µg of protein were incubated at room temperature with 1 µg of poly(dI-dC) and 0.1 µg of salmon sperm DNA in 20 µl of binding buffer (12 mM HEPES, pH 7.8, 60 mM KCl, 2 mM MgCl2, 0.12 mM EDTA, 0.3 mM DTT, 0.3 mM PMSF, 12% glycerol) for 15 min. Complementary synthetic oligonucleotides containing a canonical AP1 site was obtained from Promega and labeled with [{gamma}-32P]ATP using T4 polynucleotide kinase (Invitrogen). Labeled oligonucleotides were purified using G-25 columns (Amersham Biosciences) and used as probes (20,000 cpm/reaction) added to the reactions for an additional 15 min. Complexes were analyzed on nondenaturing (4.5%) polyacrylamide gels in TGE buffer (40 mM Tris, 270 mM glycine, 2 mM EDTA, pH 8.0) run at 13 V/cm at 4 °C. For supershift assays, 1 µg of anti-c-Fos sc-52X antibody (Santa Cruz Biotechnology) was added to the binding reaction prior to the addition of the radiolabeled probe for 15 min.

Cell Fractionation and Nuclear Translocation Assay—Nuclear extracts were separated from its corresponding cytoplasmic fractions as already described above for the electrophoretic mobility shift assays. Homogenates from the nuclear extracts were obtained by incubation with hypotonic buffer as indicated above. SDS sample loading buffer was added to samples from both fractions before loading SDS-polyacrylamide gels and transferred to Immobilon-P membranes as indicated. The protein bound to the membranes was detected by Western blot with the aid of the same anti-c-Fos antibody mentioned above.

Two-hybrid Assays (Sos Rescue System)—To assay for protein-protein interaction in yeast, we employed the Sos rescue system, which takes advantage of a Saccharomyces cerevisiae strain carrying a Cdc25 allele that displays a temperature-sensitive phenotype. This cdc25-2 strain can be propagated at 28 °C but is unable to grow at 37 °C unless hybrid proteins expressed by transfected plasmids can bring a human version of SOS, a guanine-nucleotide exchange factor for Ras, to the plasma membrane and therefore promote GTP loading on Ras and cell growth. A HeLa cells cDNA expression library fused to the Src myristoylation signal was utilized and challenged with plasmids that express fusion proteins between human SOS and p38 MAPKs. Protocols for growth of the yeast strains and transfection with plasmid DNAs have been described previously (50).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
p38{gamma} Interacts with c-Fos in a SOS Two-hybrid Assay—In order to identify unknown p38-binding proteins that might take part in p38-mediated signaling pathways, we performed an SOS yeast two-hybrid screen (50) of a HeLa cells-cDNA library fused to an Src myristoylation signal using the human p38s as bait. In this system, the bait is attached to the coding sequence of the exchange factor for Ras, SOS. Thus, only proteins that bring SOS close to the plasma membrane result in GTP loading on Ras and therefore allow growth of the cdc25ts yeast strain at the restrictive temperature of 37 °C (Fig. 1A). By using the full-length p38{gamma} cDNA as bait, we obtained several candidate clones. The sequence of one of them, clone E62-83, corresponded to amino acids 137–239 of the AP-1 member c-Fos. Fig. 1B shows that although yeast strains containing the DNA for clone E62-83 together with plasmids encoding either the bait or an empty vector grew well at 28 °C, growth at the restrictive temperature of 37 °C was only achieved when the bait was present (Fig. 1B, left panels). Positive controls using a full-length cDNA for c-Jun, a well known c-Fos-interacting protein, are depicted on the right panels.



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 1.
Double hybrid assay (Sos rescue system) aimed at screening for p38-interacting proteins. A, double hybrid assay was performed in which p38{gamma} was subcloned in a vector that expressed it as a fusion protein with SOS (Sos rescue system). This fusion protein was used as bait and challenged to a HeLa cell library in which cDNAs were expressed as fusion proteins with a myristoylation signal. Only clones in which the two fusion proteins interact can allow growth at the restrictive temperature (schematic). B, growth at 28 °C occurs in the temperature-sensitive (cdc25-2) yeast strain either in the presence or in the absence of the bait. At 37 °C growth restriction is inflicted upon those clones carrying an empty plasmid instead of either the bait or the cDNA. The photograph, left panel, shows the actual data obtained with p38{gamma} and c-Fos, and the right panel shows a positive control using c-Fos and its AP-1 partner protein c-Jun.

 
c-Fos Is Phosphorylated in Vitro by SAPKs—It is known that the reversible phosphorylation of the transcriptional activation domain (TAD) of transcription factors may result in the positive or negative regulation of its transactivating properties (23). As described previously, the C-terminal portion of c-Fos encodes a motif exhibiting transactivating potential (51). This region displays at least four MAPK potential phosphorylation sites with the consensus sequence (S/T)P located at positions Thr-232, Thr-325, Thr-331, and Ser-375 (42). As the region of c-Fos involved in the interaction with p38{gamma} comprises the first portion of its TAD, we decided to explore whether c-Fos was a target of phosphorylation by p38{gamma}, and we extended this study also to other SAPKs, including other p38 family members and JNK. HEK 293 cells were transfected with pCEFL vectors containing cDNAs for HA-tagged p38{alpha}, p38{beta}, p38{gamma}, p38{delta}, or JNK together with their specific activators, the MAPKK, MKK6 for p38 family members, or the MAPKKK MEKK for JNK. Transfection of Erk-2 along with its constitutively active kinase MEKEE was used as a positive control, as recent work demonstrated that the c-Fos TAD is phosphorylated by the Erk1/2 pathway (42). We performed in vitro kinase assays using a bacterially expressed GST chimeric protein containing the c-Fos TAD (GST c-Fos TAD) as a substrate. As shown in Fig. 2, upper panel, all SAPKs phosphorylated the c-Fos TAD in vitro. Parallel samples were incubated with GST-ATF2 or myelin basic protein as controls for the activity of the different MAPKs (Fig. 2, middle panels). Expression of the transfected kinases was controlled in a Western blot of the total lysates using an anti-HA antibody (Fig. 2, lower panel). Together, these data extended previous findings suggesting that c-Fos could act as a potential target for SAPKs besides its function as an Erk2 substrate.



View larger version (55K):
[in this window]
[in a new window]
 
FIG. 2.
Assay of c-Fos phosphorylation in vitro by SAPKs. HEK 293 cells were cotransfected with expression plasmids for HA-p38{alpha}, HA-p38{beta}, HA-p38{gamma}, HA-p38{delta}, HA-JNK, or HA-Erk2 (MAPK) along with empty vectors (–) or with plasmids expressing the corresponding upstream activators (MKK6, MEKK, or MEKEE) as indicated. The cellular lysates obtained were divided in 2 equal aliquots and immunoprecipitated using a monoclonal anti-HA antibody. Each immunoprecipitate was used to perform kinase assays using bacterially expressed GST-c-Fos TAD as substrate (upper panel) or with alternative well known substrates as positive controls (middle panels). The position and identity of each 32P-labeled substrate is indicated. In parallel, Western blot (WB) analysis was performed with anti-HA antibodies using total cell lysates to check for expression of the transfected kinases (lower panel).

 
c-Fos Is Phosphorylated in Vivo by p38 MAPKs—In order to study whether c-Fos was also phosphorylated in vivo, we analyzed the electrophoretic mobility of c-Fos by SDS-PAGE followed by Western blot, as the appearance of slow migrating bands in c-Fos is related to its phosphorylated state (42, 43, 52, 53). Thus, HEK 293 cells were cotransfected with a full-length c-Fos (pCEFL AU5 c-Fos FL) along with plasmids encoding different MAPKs and their corresponding activators. As depicted in Fig. 3A (upper panel), all the p38 kinases induce a mobility shift on c-Fos FL, as denoted by Western blotting using an anti-AU5 antibody. This change in mobility was strictly dependent on the activity of the kinases as it was only observed upon cotransfection with MKK6. Most interestingly, no shift was observed upon cotransfection with JNK or activated JNK, although comparable expression of all HA-tagged kinases was observed by using an anti-HA antibody on aliquots from the same samples run in parallel (Fig. 3A, lower panel). These results prompted us to ask whether the observed shift in c-Fos mobility, presumably due to its in vivo phosphorylation, involves any of the MAPK potential target residues located in the TAD of c-Fos. To answer this question we first performed the same mobility shift experiment, transfecting HEK 293 cells with the activated kinases and a plasmid coding for a GFP-tagged form of the c-Fos transactivation domain (pCEFL GFP c-Fos TAD). Indeed, we observed that the c-Fos TAD was shifted upon conditions in which p38 MAPKs were activated by MKK6, and again no shift was induced by activated JNK (Fig. 3B). These results suggest that c-Fos acted as an in vivo target for all p38 MAPKs but not of JNK, thus providing evidence of an unexpected specificity of SAPK signaling, as not all SAPKs lead to the phosphorylation of this transcription factor.



View larger version (72K):
[in this window]
[in a new window]
 
FIG. 3.
c-Fos phosphorylation in vivo. A, HEK 293 cells were cotransfected with pCEFL-AU5-c-Fos (full-length, FL) and pCEFL-HA-SAPKs, with or without MKK6 or MEKK as upstream activators for p38s or JNK, respectively, as indicated. Total lysates were analyzed by Western blot using an anti-AU5 antibody (upper panel). The lower panel shows transfected kinase expression as analyzed by Western blot (WB) using anti-HA antibody. B, similar experiment in which pCEFL-GFP-c-Fos TAD was used instead of pCEFL-AU5-c-Fos. Total lysates were analyzed by Western blot using an anti-GFP antibody (upper panel). The lower panel shows transfected HA kinase expression analyzed by Western blot.

 
c-Fos Phosphorylation Potentiates Its Transcriptional Activity—To analyze whether phosphorylation of the transactivation domain of c-Fos by p38 MAPKs in vivo can modulate the transactivating functions of c-Fos, we employed a heterologous system, in which the c-Fos TAD was expressed as a fusion protein with the DNA binding domain of the yeast transcription factor GAL4. The protein encoded by the chimeric plasmid pGBDX c-Fos TAD (GAL4 c-Fos TAD) was tested by its ability to stimulate transcription from a luciferase reporter plasmid controlled by GAL4-binding motifs (pGAL4-Luc) upon conditions in which p38 is activated by MKK6. Transfection of NIH 3T3 cells with these plasmids along with vectors that express different p38 MAPKs and MKK6 was performed. As shown in Fig. 4A, cotransfection of activated p38{gamma}, p38{beta}, and p38{alpha} along with pGAL4 c-Fos TAD stimulated luciferase activity by 9-, 16-, and 20-fold, respectively, when compared with samples from cells transfected with GAL4-c-Fos TAD alone taken as a reference. Remarkably, the activity of the c-Fos TAD was only slightly stimulated by activated p38{delta}, whereas no stimulation was observed when activated JNK was present, the latter in line with the data obtained testing in vivo phosphorylation. All these results indicated that activated p38{gamma}, p38{beta}, and p38{alpha} were sufficient to transactivate c-Fos but not necessarily helped to understand which endogenous p38 is involved downstream of the p38 MAPKKs. To analyze this point, we employed MEK3EE, a constitutive active mutant MAPKK for p38s (39) which, because of mutations in its own activation domain, has a strong kinase activity toward the p38s. In fact, this activated molecule activates the GAL4-c-Fos TAD without the need of cotransfecting wild type p38s. As depicted in Fig. 4B, when MEK3EE was coexpressed with the AF mutant form of p38s that acted as dominant negatives for endogenous p38s (49), MEK3EE-induced c-Fos transcriptional activity was inhibited to different degrees, with p38{alpha}, -{beta}, and -{delta} being the most potent inhibitors. Taken together, these data suggest that the transcriptional activity of c-Fos can be differentially controlled by phosphorylation by specific members of the p38 group of SAPKs within the MAPK superfamily.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 4.
Analysis of SAPKs-triggered c-Fos post-transcriptional activation. A, NIH 3T3 cells were cotransfected with the reporter plasmid pGAL4-LUC (100 ng/each), the fusion protein expression plasmid for GAL4-c-Fos TAD (pCDNA3 GBDX-c-Fos TAD, 5 ng/each), and pRNull (10 ng/each), together with pCEFL HA-p38{alpha}, HA-p38{beta}, HA-p38{gamma}, HA-p38{delta}, or HA-JNK, with or without upstream p38 or JNK activators (MKK6 or MEKK, respectively). 24 hours after transfection, cells were harvested, and dual luciferase activities were determined. Data shown correspond to the average of duplicates from a representative experiment of three performed. B, similar experiment was performed using transfected MEK3EE to activate endogenous p38 kinases along with dominant negative forms of the four p38 variants as indicated. Data from one representative experiment of five performed is shown. C, NIH 3T3 cells were cotransfected with the reporter plasmid pAP-1-LUC (100 ng/each), pCEFL AU5 c-Fos (100 ng/each), and pRNull (10 ng/each), along with pCEFL HA-p38{alpha}, HA-p38{beta}, HA-p38{gamma}, HA-p38{delta}, and the p38 MAPK activator pCEFL-GST-MKK6 as indicated in the figure. 24 hours after transfection cells were harvested and dual luciferase activities were determined. Data shown correspond to duplicates that are from a representative experiment of three performed.

 
Transactivation of c-Fos by p38 MAPKs Induces AP-1 Activity—Based on our results, we tested whether the transactivating effect of p38 MAPKs on c-Fos resulted in a greater AP-1 activity, as c-Fos can dimerize with Jun proteins and activate promoters that contain AP-1-binding sites. Thus, we used a reporter plasmid that carries a luciferase gene under the control of seven tandem repeats of an AP-1-response element (pAP-1-Luc). We cotransfected NIH 3T3 cells with pAP-1-Luc, p38 MAPKs, and MKK6 with or without pCEFL AU5 c-Fos FL. Fig. 4C shows that addition of AU5 c-Fos FL resulted in an increase in AP-1-driven luciferase activity; as expected, and this response was greatly enhanced by the cotransfection of activated p38s. Most interestingly, and according to data obtained with the Gal4 c-Fos protein, activated p38{alpha} and -{beta} had a stronger effect on the activity of this reporter when compared with the effect of p38{gamma} and -{delta}. Moreover, p38{alpha} and -{beta} were able to activate pAP-1-Luc even in the absence of ectopic c-Fos, which suggested that they exert a potent effect on the endogenous c-Fos protein. Hence, these data indicate that the transactivation of c-Fos by p38 MAPKs stimulate gene expression when under the control of AP-1-binding elements.

UV Light Induces c-Fos Phosphorylation by Serine-Threonine Kinases—Extracellular stimuli that induce cellular stress are strong activators of p38 and JNK activity and can trigger c-Jun phosphorylation (5, 11). In view of our data, we explored the in vivo phosphorylation of c-Fos FL, when cells were exposed to UV radiation. HEK 293 cells transfected with pCEFL AU5 c-Fos FL were stimulated by exposure to UV light and were collected at different times. Total lysates were analyzed by SDS-PAGE followed by immunoblotting using an anti-AU5 antibody. We observed that the exposure of cells to UV light induced a time course-dependent phosphorylation of c-Fos as judged by a mobility shift of this protein that started 15 min after treatment and peaked at 60 min (Fig. 5A). Similar results were obtained when treating the cells with anisomycin and incubating the membranes with an anti-c-Fos (data not shown). In order to validate that the changes in c-Fos mobility were due to phosphorylation, we incubated UV-treated samples with the serine-threonine phosphatase PP2A. The accumulation of slow migrating bands 30 min after UV exposure was reduced by PP2A treatment, suggesting that the shift induced by this stress is a consequence of the primary addition of phosphate groups on serine and/or threonine residues on the c-Fos protein (data not shown). Altogether, these data showed that c-Fos is indeed a target of phosphorylation events induced by cellular stress.



View larger version (34K):
[in this window]
[in a new window]
 
FIG. 5.
UV-triggered phosphorylation of c-Fos is mediated by different members of the p38 MAPK family. A, HEK 293 cells were transfected with pCEFL-AU5-c-FOS. 24 hours later, cells were stimulated or not with UV light for 1 min using a Stratalinker as a radiation source and collected at 5, 15, 30, 45, or 60 min after stimulation. Cellular lysates were analyzed by Western blot (WB) using an anti-AU5 antibody. B, HEK 293 cells were cotransfected with pCEFL AU5 c-Fos (wild type), pCEFL HA-p38{alpha}, HA-p38{beta}, HA-p38{gamma}, HA-p38{delta}, or HA-JNK and starved overnight after transfection. Then the cells were stimulated with UV and collected 5 min later. Total lysates were analyzed by Western blot. The upper panel shows the mobility shift of AU5 c-Fos in a Western blot using anti-AU5 antibody. The 2nd panel shows the expression of the kinases transfected using anti-HA antibody. The 3rd and 4th panels correspond to a similar experiment performed in cells transfected with a construct that expresses a c-Fos mutant that has four key residues (threonines 232, 325, and 331 and serine 374) replaced by alanines instead of wild type c-Fos. C, HA-tagged SAPKs expression vectors were transfected in HEK 293 cells. 24 hours after transfection cells were starved for 2 h and stimulated with UV or anisomycin for 20 min; cells were collected, and the total lysates were assayed by Western blot using anti-phospho-p38 (P-p38) or anti-phospho-JNK (P-JNK) to analyze the extent of SAPKs phosphorylation. In parallel, samples were tested using an anti-HA antibody (lower panel) to check the amount of total kinase present in the transfected cells.

 
UV Light Induces c-Fos Phosphorylation in Specific Serine/Threonine Residues through SAPKs of the p38 Family—In view of our observations, we decided to dissect the role of different p38s in the pathways that lead to UV-induced c-Fos phosphorylation. We took advantage of the fact that at 5 min of treatment, UV light or anisomycin induced no significant shift on c-Fos mobility (Fig. 5A and data not shown). Thus, we treated HEK 293 cells transfected with AU5-c-Fos FL alone or along with the HA-tagged forms of p38{alpha} p38{beta}, p38{gamma}, p38{delta}, or JNK, and we analyzed the phosphorylation status of c-Fos in total cell lysates by Western blot using an anti-AU5 antibody. Cotransfection of all p38 family members, which alone did not display any demonstrable effect, dramatically enhanced the effect of UV light on the mobility shift of c-Fos after 5 min of treatment, whereas JNK or Erk2 did not (Fig. 5B, upper panels and data not shown). Treatment with anisomycin under the same conditions gave nearly identical results (data not shown).

The analysis of the primary structure of the TAD in the c-Fos protein reveals the existence of four putative MAPK phosphorylation sites displaying the consensus sequence of serine/threonine followed by a proline, Thr-232, Thr-325, Thr-331, and Ser-374. To confirm that the shift induced in c-Fos was due to phosphorylation by p38 MAPKs in any of these sites, cells were transfected with a c-Fos mutant that has these four key residues mutated to alanines along with constructs expressing the same HA-tagged kinases. Upon UV stimulation no mobility shift in the position of bands developed by the c-Fos antibody was observed when using this mutant (Fig. 5B, lower panels), which indicated that changes in c-Fos mobility were due to the presence of these MAPK target residues. These results indicate that this shift was most likely due to phosphorylation exerted by UV light-activated p38 kinases.

To confirm the activation of SAPKs in these cells under our treatment conditions, we analyzed the same total lysates by Western blot using an anti-phospho-p38 antibody capable of recognizing the phosphorylated state of all four isoforms or an anti-phospho-JNK antibody. As expected, Fig. 5C (upper panels) shows that all these kinases were activated under our experimental conditions by UV light or anisomycin exposure. Similar expression levels of the transfected kinases were assessed using an anti-HA antibody (Fig. 5C, lower panels). These results indicate that, most likely, all the p38 MAPKs but not JNK can be involved in stress-induced c-Fos phosphorylation on specific serine and threonine residues.

In view of the role of the p38s in UV-induced c-Fos phosphorylation, we used an additional approach, and we confirmed the data in cells in which endogenous p38 signaling is deterred either by using a specific p38 pharmacological inhibitor, SB 203580 (54), or by expression of dominant negative forms of p38. Although p38{gamma} and -{delta} are refractory to the effect of SB 203580, and there are no specific inhibitors for these kinases, the drug allows us to score at least the participation of endogenous p38{alpha} and -{beta} in the various effects of UV light on c-Fos. Thus, we pretreated AU5 c-Fos FL-transfected cells with the SB 203580 compound, and we compared its effect with that of the JNK and MEK inhibitors, SP6000125 (55) and U0126 (56), respectively, followed by treatment with UV light or anisomycin for 30 min. Most interestingly, only SB 203580 was able to reduce the stress-induced mobility shift in c-Fos, whereas the other compounds had no significant effect on it as denoted by Western blots developed using an AU5 antibody (Fig. 6A, upper panel, and data not shown). To take this a step forward and explore the effect of the UV-p38-activated pathway on endogenous c-Fos, we repeated the experiment in identical conditions in nontransfected cells. Identical results were observed as endogenous c-Fos mobility was affected in a p38-dependent manner similar to that of the overexpressed c-Fos, as judged by the use of an anti-C-terminal c-Fos-specific antibody (Fig. 6A, lower panel). In line with this, expression of a dominant negative form of p38{alpha} inhibited the mobility shift induced upon AU5 c-Fos in cells activated by UV light (Fig. 6B). Together, these data suggest an important role for SB 203580-sensitive p38s as mediators of UV-induced c-Fos phosphorylation.



View larger version (43K):
[in this window]
[in a new window]
 
FIG. 6.
Endogenous c-Fos phosphorylation triggered by UV-induced activation of p38 family SAPKs. A, HEK 293 cells transiently transfected with pCEFL-AU5-c-Fos were grown in serum-free media overnight after transfection. Cells were incubated in the absence or presence of the p38 inhibitor SB 203580 at 10 µM for 1 h (upper panel) before UV stimulation. 20 min after stimulation, the cells were harvested and the total lysates analyzed by Western blot (WB) using an anti-AU5 antibody. The lower panel shows a similar experiment performed on untransfected HEK 293 cells and developed by Western blot using an antibody targeted to the endogenous c-Fos protein. B, a similar experiment was performed in cells transfected with pCEFL AU5 c-Fos. Instead of the pharmacological inhibitor, a dominant negative form of p38{alpha} (AF) was used to inhibit endogenous p38 signaling. The position of the shifted c-Fos band is highlighted with an arrow on each image.

 
UV-induced p38 Promotes Nuclear Translocation of c-Fos— As MAPKs translocate to the nucleus upon stimulation (10), and the cellular localization of c-Fos seems to vary under different conditions (5759), we studied whether UV treatment had an effect on c-Fos cellular localization and its relationship with the localization of different p38s. HEK 293 cells were cotransfected with plasmids that express GFP-tagged forms of c-Fos and HA-p38s and were stimulated with UV light, fixed after 30 min, and analyzed using light fluorescence microscopy. We observed that after UV exposure, p38{gamma} and -{alpha} amounts were increased in the nucleus (Fig. 7A and data not shown, respectively) where they were localized along with c-Fos as denoted by the overlay of the HA (red) and GFP (green) that yielded a yellow signal. Most interestingly, p38{beta} was found in the nucleus and was colocalizing with c-Fos even before UV treatment, whereas p38{delta} did not colocalize with c-Fos in the nucleus but in the cytosol upon stimulus (data not shown). These findings may help to explain the differences observed in the transactivation potential of each p38 on c-Fos evidenced by the reporter assays (see above and Fig. 4).



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 7.
UV-induced nuclear translocation of c-Fos is dependent on p38 signaling. A, cells were seeded on coverslips and transfected as in previous figures with pCEFL-GFP-c-Fos and each of the pCEFL-HA-p38s as indicated; p38{gamma} is shown. 16 hours after incubation in serum-free media, cells were stimulated with or without UV light, fixed, and analyzed by immunofluorescence for GFP and using an anti-HA-specific antibody followed by incubation with a rhodamine-labeled secondary antibody for p38 staining. Nuclear staining is denoted by 4,6-diamidino-2-phenylindole (DAPI), as indicated. Photographs shown are representative of at least 5–10 different fields. B, untransfected HEK 293 cells were stimulated with UV light with or without previous treatment with the p38 kinase inhibitor SB 203580 or left untreated as indicated. Nuclear (black bars) and cytoplasmic (white bars) fractions were prepared and run in separate lanes of an SDS-polyacrylamide gel, transferred to nitrocellulose, and challenged with an anti-c-Fos antibody. Bands corresponding to endogenous c-Fos were scanned and quantitated. The bars show relative intensity to the amount present in the nuclear fraction of untreated cells. The numbers on the line above each pair of bars indicate the ratio between the intensity of the band that appears in the nuclear fraction and the band in the cytoplasmic fraction. The data are representative of three different experiments with similar results. C, cells were seeded and transfected as indicated above, along with a vector that expresses a dominant negative form of MEK3AA. Cell nuclei from UV-stimulated (or control) cells are visualized by propidium iodide staining and subcellular position of GFP-c-Fos with the aid of confocal microscopy.

 
In addition, we studied the nuclear translocation of endogenous c-Fos proteins in untransfected cells treated or untreated with the p38 inhibitor prior to UV stimulation by comparing the ratio between the intensity of the bands corresponding to c-Fos obtained by Western blot from nuclear and cytoplasmic fractions. Although overexpressed c-Fos is mainly in the cytoplasm under basal conditions (Fig. 7B), a small fraction of endogenous c-Fos remains in the nucleus, and the ratio between nuclear and cytosolic protein is around 0.4. Upon UV stimulation, c-Fos migrated from the cytosol to the nucleus. However, the p38 kinase inhibitor prevented the nuclear translocation of c-Fos. Similar results were obtained by expressing a dominant negative form of the p38 signaling pathway intermediate, MEK3AA (39). As shown in Fig. 7C, GFP c-Fos localized mainly in the cytosol of NIH 3T3 cells, but upon UV stimulation, a significant fraction translocated to the nuclear region. Moreover, this UV-induced translocation was strongly inhibited when cells were cotransfected with MEK3AA. Together, these data indicate that c-Fos is a substrate of the {alpha} and/or {beta} isoforms of p38 kinases and depends on this phosphorylation to translocate to the nucleus as the result of their activation induced by UV light.

UV-induced AP1-DNA Binding Complexes Require p38 Activity and Contain c-Fos—As UV radiation results in p38-mediated c-Fos phosphorylation and nuclear translocation, we sought to examine the presence of this factor in UV-induced AP1-DNA binding complexes. Electromobility shift assays were performed on labeled AP-1 oligonucleotides preincubated with nuclear extracts coming from untransfected HEK 293 cells treated or not with the SB 203580 compound prior to UV exposure. As shown in Fig. 8, incubation of labeled oligonucleotides with nuclear extracts from cells in basal conditions rendered the assembly of an AP1-DNA complex as indicated. As expected, UV light induced a stronger AP1-DNA binding activity as denoted by the presence of a band of higher intensity (Fig. 8, 1st and 2nd lanes), which was prevented by pretreatment with the inhibitor SB 203580 (3rd lane). To determine the presence of c-Fos in these complexes, we incubated nuclear extracts from UV-stimulated cells with an antibody against the C-terminal portion of c-Fos protein, which resulted in the presence of a band of slower mobility corresponding to the heavier antibody-AP1-DNA complex (Fig. 8, 5th lane). All these data combined suggest that in cells stimulated by UV light, AP1-DNA binding activity is enhanced, and this is dependent on p38 activity and c-Fos, thus supporting a critical role for p38{alpha} and/or -{beta} in mediating stress-induced c-Fos phosphorylation, nuclear translocation, and gene transcription activation in response to UV radiation.



View larger version (39K):
[in this window]
[in a new window]
 
FIG. 8.
UV-induced AP-1 complex assembly is dependent on p38 signaling and c-Fos. Electromobility shift assays were performed on nuclear extracts of HEK-293T cells treated (or not) with UV radiation incubated with a labeled oligonucleotide encoding the AP-1 binding consensus sequence. Controls include SB 203580-treated cells, incubation with excess amounts of the unlabeled oligonucleotide, and with an anti-c-Fos antibody as indicated. The positions of the AP-1-binding protein complexes are indicated by arrowheads.

 
Individual c-Fos Phosphorylation Sites Are Differential Targets for p38 MAPKs—After determining the role of UV-induced, p38-mediated phosphorylation on the c-Fos TAD transactivation and the relevance of the MAPK target sites on it, we decided to study the contribution of each of the four residues to this response. For these studies, we employed a series of c-Fos TAD variants designed to keep only one phosphorylation site intact, while replacing the rest of them by nonphosphorylatable alanine residues. We expressed these mutant proteins as GST fusion chimeras in bacteria and used them as substrates for in vitro p38 kinase assays. Fig. 9A shows a Coomassie Blue staining of equivalent amounts of each mutant protein used in the assays. As depicted in Fig. 9B, c-Fos TAD phosphorylation by activated p38{alpha}, -{beta}, and -{delta} was abolished when all four MAPK target residues are mutated (GST c-Fos TAD MUT), which was aligned with the fact that this mutant does not present any apparent shift when cells are exposed to UV light and cotransfected with different p38s (Fig. 5B). According to this evidence, p38{gamma} appeared to induce phosphorylation on a non-MAPK target site as the c-Fos TAD MUT was still weakly phosphorylated. Analyzing each site in particular, it was interesting to note that Thr-325 seemed to be the only site that could be significantly phosphorylated when left alone on the TAD, suggesting that this residue may represent a preferential target for these kinases in vitro. On the other hand, the phosphorylation of Thr-232 and Ser-374 by p38{alpha} was almost undetectable, whereas all other kinases had a marginal effect (considering that the band that appeared in the lane corresponding to p38{gamma} was also present with similar intensity in the c-Fos TAD MUT). Thr-331 was just slightly phosphorylated by p38{alpha} and -{beta}, and no detectable phosphorylation was induced by p38{gamma} or -{delta}. These results suggest that each site can be phosphorylated in vitro with different effectiveness by a distinct set of p38 MAPKs, displaying a certain pattern of specificity and transactivating potential.



View larger version (36K):
[in this window]
[in a new window]
 
FIG. 9.
Analysis of putative SAPK phosphorylation sites on c-Fos and its implication in transcriptional activation. A, the panel shows Coomassie Blue staining of an SDS-polyacrylamide gel obtained running different GST c-Fos TAD fusion proteins purified from bacteria. GST c-Fos wild type (wt), a mutant in which threonines 232, 325, and 331 and serine 374 are mutated (mut), threonine 232 conserved (T232), threonine 325 conserved (T325), threonine 331 conserved (T331), or serine 374 conserved (S374). B, the schematic on the right represents the putative MAPK phosphorylation sites in the c-Fos TAD and the different point mutants utilized in this assay as described above. The black ovals represent the phosphorylation sites that are conserved in each mutant, and the white ovals indicate the corresponding residues replaced by alanine. The autoradiograms on the left correspond to kinase assays performed using as substrates the same amount of protein loaded for the Coomassie Blue stainings. HEK 293 cells were transfected with the different HA p38s along with MKK6 or empty vector. Cells were collected and the cleared lysates immunoprecipitated to perform in vitro kinase assays using the different variants of bacterially expressed GST c-Fos TAD fusion proteins as substrates. C, NIH 3T3 cells were transfected with the reporter plasmid pTATA GAL4-LUC, pRNull, the different pCEFL-HA-p38 SAPKs, pCEFL-GST-MKK6, and different pCDNAIIIGBDX-c-Fos TAD mutants as indicated. Total amount of transfected DNA was adjusted with pCDNA3-{beta}-galactosidase. 24 hours after transfection cells were lysed and assayed for dual luciferase activities. The data represents firefly luciferase activity normalized by Renilla luciferase activity present in each sample expressed as fold induction relative to control. Similar results were obtained in three additional experiments.

 
Multiple MAPK Phosphorylation Sites on the c-Fos Transactivation Domain Are Required to Achieve p38-induced Transcriptional Activity—As the in vitro phosphorylation of each MAPK target site within the c-Fos TAD by p38s is different, we explored the participation of each site in c-Fos transcriptional activity in vivo using the GAL 4 Luc reporter system. We transfected NIH 3T3 cells with the different TAD mutants subcloned as Gal4-TAD chimeras together with the different p38 kinases and MKK6. Fig. 9C shows that removing all four MAPK sites abolished transcriptional activation of the chimera, which is coincident with the fact that the c-Fos TAD MUT is not phosphorylated in vitro. Adding back only one particular site at a time did not restore the transcriptional activity of c-Fos in response to any of the p38 MAPKs. These data indicate that despite the fact that some sites can be phosphorylated in vivo when present alone on the TAD, multiple sites are required to achieve maximal phosphorylation and consequent transcriptional activity.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Activation of early genes is a common feature to the cellular response to both cell-growth promoting agents and cellular stressors. Particularly, the level of expression of members of the AP-1 transcription factor family, such as c-Jun and c-Fos, has been shown to increase shortly after the exposure of cells to either mitogens or UV light (23, 60, 61). However, in order to exert its transcriptional activation effect on target genes that may ultimately be responsible for the onset of cellular responses, these proteins require modification by the addition of phosphate groups. Thus, MAPK cascades play an important role in both the activation of the early gene promoters and the transactivation of pre-existing and newly synthesized proteins. Among them, phosphorylation of c-Jun by JNK has received considerable attention. On the other hand, the effect of signaling cascades on c-Fos phosphorylation is much less understood. A variety of proteins have been reported as putative c-Fos kinases in the past (43, 52, 53, 62, 63). In addition, c-Fos has been shown recently to be a target for MAPK activity upon mitogenic stimulus (42). In this study we provide evidence that exposure of cells to UV light triggers the activation of members of the p38 MAPK family, which in turn phosphorylate c-Fos in its transcriptional activation domain, leading to its enhanced activity as a transcription factor.

Searching for putative p38 binding partners by a double-hybrid strategy, we identified c-Fos as an insert in various clones that were rendered positive. In order to analyze the biochemical and biological consequences of the c-Fos/p38 interaction, we initially performed in vitro assays to corroborate the function of c-Fos as a substrate for p38. We found that the four p38 isoforms immunoprecipitated from cultured cells effectively transfer phosphate groups from ATP to bacterially expressed c-Fos proteins. As phosphorylation of a given substrate by a partner protein kinase in vitro does not necessarily reflect a functional interaction in vivo, we tested the mobility of c-Fos proteins by Western blots of extracts from cultured cells expressing active kinases, as changes in mobility are considered to be indicative of alterations in the phosphorylation state of c-Fos (42, 53). We observed a remarkably slower mobility of full-length c-Fos when cells were cotransfected with all the different p38s and its activator MKK6. The same shift was observed when using only the c-Fos TAD, confirming that in vivo phosphorylation by p38s is most likely to occur on its C-terminal region.

Phosphorylation of the c-Fos/TAD promoted c-Fos-mediated transcriptional activation, as we show by using a GAL4-c-Fos TAD, assayed upon conditions in which p38s are activated. In turn, suppression of endogenous p38 signaling by dominant negative p38s resulted in limited activity of the GAL4 luciferase reporter. These data were confirmed using a full-length c-Fos and an AP-1 reporter system. Although every p38 seemed to promote transcriptional activation of the c-Fos protein, differences in the intensity of the effect became evident, with p38{alpha} and p38{beta} being the strongest activators, whereas p38{gamma} and p38{delta} had a much more modest effect, even when they phosphorylate the c-Fos TAD in vivo and in vitro. Taken together these results suggest that the capacity of the different p38s to regulate c-Fos may be attributable not only to the ability of these kinases to mediate c-Fos phosphorylation but also to the possibility that p38s may recruit additional components to the transcriptional machinery that, depending on which p38 is involved, might be critical for changes in transcriptional activity. In addition, the cellular localization of these molecules can be a determinant of the resulting differential transcriptional activation. For example, after UV exposure, HA-tagged p38{alpha} and -{gamma} are increased in the nucleus where they localized along with c-Fos. Most interestingly, p38{beta} was found in the nucleus and colocalizing with c-Fos even before UV treatment, whereas p38{delta} did not colocalize with c-Fos in the nucleus but in the cytosol upon stimulus (data not shown). The fact that p38{alpha}, -{beta}, and -{gamma} localized to the nucleus after stimulation and p38{delta} remained cytosolic may also help to explain the differences observed in the p38-induced c-Fos transactivation potential as evidenced by the reporter assays. For instance, although p38{delta} can phosphorylated c-Fos, this does not lead to c-Fos transcriptional activation because the protein does not go to the nucleus (Figs. 2, 3, 4). This also helps to explain why p38{delta} AF (dominant negative form) can still inhibit MEK3EE-induced c-Fos transactivation, as most likely the AF mutant also sequesters c-Fos in the cytosol. This is not surprising because although there are many similarities between p38 family members, there are also some important differences that suggest that they may regulate specific functions (12). This last point is evidenced by the fact that different p38 isoforms have opposite effects on AP-1-dependent transcription through the regulation of c-Jun (49).

Most interestingly, the phosphorylation of c-Fos in response to stress-activating pathways and the simultaneous overexpression of each of the p38 family members, but not by JNK, indicate that only UV-activated p38 kinases can mediate this event. In line with this, pretreatment of cells with the p38 inhibitor SB 203580 (54) prevented the UV-induced mobility shift and AP-1 complex assembly, whereas the MEK inhibitor U0126 (56) produced no effect in the position of the c-Fos bands in UV-treated cells (not shown) indicating that, in contrast to what is observed upon activation of tyrosine kinase receptors, the Erk1/2 signaling pathway may not be involved in the c-Fos response to UV light. Similarly, cotransfection with Erk2 or Erk5, both shown to phosphorylate c-Fos upon platelet-derived growth factor stimulation or activating mutations, respectively, did not induce any changes in the apparent molecular weight of the transcription factor upon UV treatment (data not shown) (42, 43, 53). Although the inhibitor SB 203580 does not allow us to score the participation of p38{gamma} or p38{delta}, the fact that p38{alpha} and p38{beta} are the strongest activators of c-Fos transcriptional activity and that the effect of UV light on the endogenous c-Fos phosphorylation, nuclear translocation, and AP1-DNA binding activity is almost abolished by the SB 203580 most likely indicates that the latter isoforms play a predominant role in the UV-stimulated signaling pathway. On the other hand, the fact that the UV-induced c-Fos mobility shift was reverted by phosphatase treatment and was not seen when using a mutant that has been depleted of critical serines and threonines indicates that these changes were the consequence of the primary addition of phosphate groups on these residues. However, due to the severity of the shift, we cannot discard the possibility that further post-transcriptional modifications may also occur on the c-Fos TAD following phosphorylation. Regarding the analysis of the participation of each of these sites on the transactivation of c-Fos, the situation appears to be quite more complex than in the case of c-Jun phosphorylation by JNK where only two sites, serine 63 and 73, are the critical residues. Thr-325 appears to be the only target site when left alone in the TAD for p38 kinases in vivo. However, and despite this phosphorylation, c-Fos does not regain transcriptional activity in vivo after restoration of serines or threonines one by one, which indicates that none of the sites seem to be sufficient by themselves to exert transcriptional activation, and that more than one site is required to achieve maximal phosphorylation and consequent transcriptional activity. Particularly interesting is the fact that p38{gamma} still can induce the phosphorylation of the TAD in the mutant that has the four putative MAPK phosphorylation sites mutated to alanines as denoted by the presence of a strong band. This might be the consequence of the phosphorylation on a non-MAPK target residue, most likely in an indirect fashion through another associated kinase brought down during the immunoprecipitation step. As the activating or repressing nature of this phosphorylation has not been established, one could speculate that this can affect the fact that although p38{gamma} phosphorylates c-Fos and localizes to the same cellular compartment upon activation, it is nonetheless only a weak inducer of its transcriptional activity.

Although the effects of UV-induced p38 on the c-fos promoter have already been reported (4446), our data show for the first time that p38 promotes the phosphorylation of the c-Fos transcription factor affecting its cellular localization and transcriptional activity. In summary, our findings support a model by which UV stimulation leads to c-Fos phosphorylation through p38s, and in turn multiple putative phosphorylation sites on the c-Fos TAD are required for p38-mediated transcriptional activation of c-Fos (Fig. 10). Indeed, we can envision that UV irradiation triggers multiple signaling pathways that stimulate the activation of the promoters for c-Jun and c-Fos (5) and enhances the transcriptional activities of AP-1 through the concomitant phosphorylation of c-Jun by JNK, as reported previously (3, 21, 64), and c-Fos by p38 family members as shown in this study.



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 10.
UV light activates AP-1 by inducing phosphorylation of c-Jun and c-Fos. Following UV irradiation, parallel signaling pathways that converge on AP-1 family transcription factors are triggered. Our findings provide evidence that c-Fos is phosphorylated by p38, thus ultimately contributing to AP-1 activation together with the concomitant phosphorylation of c-Jun by JNK.

 

    FOOTNOTES
 
* This work was supported in part by research grants awarded by Fundación Antorchas, Ministerio de Salud (Carrillo-Onativia), Universidad de Buenos Aires, Conicet, and Foncyt (Argentina) (to O. A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ Recipient of a UICC International Cancer Technology transfer fellowship. Back

** To whom correspondence should be addressed. Tel.: 54-11-4576-3368; Fax: 54-11-4576-3321; E-mail: ocoso{at}fbmc.fcen.uba.ar.

1 The abbreviations used are: SAPK, stress-activated kinase; AP-1, activator protein 1; GFP, green fluorescent protein; MAPK, mitogen-activated kinases; AU5, epitope tag peptide, AU5; HA, epitope tag peptide hemagglutinin; GST, glutathione S-transferase; JNK, c-Jun N-terminal kinase; ERK, extracellular signal-regulated kinase; MAPKKs, MAPK kinases; MEK, MAPK/ERK kinase; MOPS, 4-morpholinepropanesulfonic acid; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride; PBS, phosphate-buffered saline; wt, wild type; TAD, transcriptional activation domain; FL, full-length; mut, mutant. Back


    ACKNOWLEDGMENTS
 
We thank members of Laboratorio de Fisiología y Biología Molecular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (especially Lorena Franco and Carolina Domaica) and members of Oral and Pharyngeal Cancer Branch, NIDR, National Institutes of Health (especially Saula Ravasi, Hans Rosenfeld, Akrit Sodhi, and Mario Chiariello). We thank Ami Aronhein for the kind and generous advice. We also thank Alberto Kornblihtt for constant unconditional support.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Dent, P., Yacoub, A., Contessa, J., Caron, R., Amorino, G., Valerie, K., Hagan, M. P., Grant, S., and Schmidt-Ullrich, R. (2003) Radiat. Res. 159, 283–300[Medline] [Order article via Infotrieve]
  2. Dent, P., Yacoub, A., Fisher, P. B., Hagan, M. P., and Grant, S. (2003) Oncogene 22, 5885–5896[CrossRef][Medline] [Order article via Infotrieve]
  3. Wisdom, R. (1999) Exp. Cell Res. 253, 180–185[CrossRef][Medline] [Order article via Infotrieve]
  4. Huang, C., Ma, W. Y., and Dong, Z. (1999) Oncogene 18, 2828–2835[CrossRef][Medline]